Abiopharma

News list

📋 KARL DAHLQUIST (Officer) plans to sell 9K shares of ATRICURE, INC. (at $48.89 each, total $458K) Filed: Aug 24, 2026 | ID: 008582

Full text

News bot Aug. 24, 2026, 8:12 p.m.
📋 Form 144 Filing: KARL DAHLQUIST

Company: ATRICURE, INC.

Filing Date: 2026-08-24

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 9,370
- Price per Share: $48.89
- Total Value: $458,091.28
- Planned Sale Date: 2026-08-24
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-51470
- Issuer Contact Phone: (513) 755-4100
- Issuer Address: 7555 Innovation Way, Mason, OH, 45040
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 50866294.0
- Number of Securities to be Sold: 5
- Signature: /s/ Karl Scott Dahlquist